Potential of GJA8 gene variants in predicting age-related cataract: A comparison of supervised machine learning methods.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 03 08 2022
accepted: 11 05 2023
medline: 4 9 2023
pubmed: 31 8 2023
entrez: 31 8 2023
Statut: epublish

Résumé

Cataracts are the problems associated with the crystallins proteins of the eye lens. Any perturbation in the conformity of these proteins results in a cataract. Age-related cataract is the most common type among all cataracts as it accounts for almost 80% of cases of senile blindness worldwide. This research study was performed to predict the role of single nucleotide polymorphisms (SNPs) of the GJA8 gene with age-related cataracts in 718 subjects (400 age-related cataract patients and 318 healthy individuals). A comparison of supervised machine learning classification algorithm including logistic regression (LR), random forest (RF) and Artificial Neural Network (ANN) were presented to predict the age-related cataracts. The results indicated that LR is the best for predicting age-related cataracts. This successfully developed model after accounting different genetic and demographic factors to predict cataracts will help in effective disease management and decision-making medical practitioner and experts.

Identifiants

pubmed: 37651414
doi: 10.1371/journal.pone.0286243
pii: PONE-D-22-21782
pmc: PMC10470928
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0286243

Informations de copyright

Copyright: © 2023 Zafar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Mol Vis. 2008;14:1850-5
pubmed: 18941546
PLoS Genet. 2009 Jul;5(7):e1000584
pubmed: 19649315
Nucleic Acids Res. 1989 Oct 25;17(20):8390
pubmed: 2813076
World J Diabetes. 2019 Mar 15;10(3):140-153
pubmed: 30891150
Ophthalmic Res. 1997;29(2):83-90
pubmed: 9154534
PLoS One. 2014 Nov 04;9(11):e112054
pubmed: 25369040
Mol Vis. 2008;14:2042-55
pubmed: 19005574
Am J Ophthalmol. 2012 Jul;154(1):29-38.e2
pubmed: 22541931
Invest Ophthalmol Vis Sci. 2001 Mar;42(3):601-5
pubmed: 11222516
Hum Genet. 2018 Dec;137(11-12):897-904
pubmed: 30349978
Int J Clin Exp Med. 2015 Oct 15;8(10):19448-53
pubmed: 26770590
Ups J Med Sci. 2020 Nov;125(4):311-315
pubmed: 32757792
Mol Vis. 2008 Mar 04;14:418-24
pubmed: 18334966
Stat Med. 2020 Sep 30;39(22):2980-3002
pubmed: 32667093
Yonsei Med J. 2015 Nov;56(6):1663-70
pubmed: 26446652
Ophthalmology. 2016 Aug;123(8):1704-1710
pubmed: 27282285
Mol Vis. 2011;17:1553-8
pubmed: 21686326
Mol Vis. 2011 Feb 26;17:621-6
pubmed: 21386927
Mol Biol Rep. 2011 Feb;38(2):1301-7
pubmed: 20582632
Nat Rev Dis Primers. 2015 Jun 11;1:15014
pubmed: 27188414
FEBS Lett. 2011 Dec 15;585(24):3884-9
pubmed: 22085609
N Engl J Med. 2000 Jun 15;342(24):1786-90
pubmed: 10853001
J Healthc Eng. 2021 Jan 27;2021:6679512
pubmed: 33575021
Invest Ophthalmol Vis Sci. 2012 Jun 22;53(7):3885-95
pubmed: 22599585
Br J Ophthalmol. 2022 Nov;106(11):1503-1507
pubmed: 34039562
Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6253-61
pubmed: 20610838
Lancet. 2005 Feb 12-18;365(9459):599-609
pubmed: 15708105
Optom Vis Sci. 2012 Aug;89(8):1165-71
pubmed: 22797512
J Cell Biol. 1998 Nov 2;143(3):815-25
pubmed: 9813099
Br J Ophthalmol. 2004 Jan;88(1):2-3
pubmed: 14693758
PLoS One. 2014 Jan 08;9(1):e85068
pubmed: 24416342
Adv Clin Exp Med. 2015 Jan-Feb;24(1):113-9
pubmed: 25923095
Sci Rep. 2019 May 30;9(1):7704
pubmed: 31147560
Indian J Ophthalmol. 2019 Apr;67(4):477-483
pubmed: 30900578
PLoS One. 2013 Aug 16;8(8):e71003
pubmed: 23976972
PLoS One. 2017 Mar 2;12(3):e0172092
pubmed: 28253266
Can J Ophthalmol. 2013 Aug;48(4):251-8
pubmed: 23931462
Ophthalmology. 2018 Dec;125(12):1844-1853
pubmed: 30077615
Mol Syndromol. 2017 Jun;8(4):179-186
pubmed: 28690483
BMC Cell Biol. 2017 Jan 17;18(Suppl 1):6
pubmed: 28124626
Proc Natl Acad Sci U S A. 2004 Oct 5;101(40):14485-90
pubmed: 15452352
Ophthalmic Genet. 2016;37(1):19-24
pubmed: 24754249

Auteurs

Saba Zafar (S)

Department of Biochemistry and Biotechnology, The Women University, Multan, Pakistan.
Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Multan, Pakistan.

Haris Khurram (H)

Department of Sciences and Humanities, National University of Computer and Emerging Sciences, Chiniot-Faisalabad Campus, Chiniot, Pakistan.

Muhammad Kamran (M)

Department of Medical Laboratory Technology, Islamabad Medical & Dental college, Islamabad, Pakistan.

Madeeha Fatima (M)

Department of Zoology, The Women University, Multan, Pakistan.

Aqsa Parvaiz (A)

Department of Biochemistry and Biotechnology, The Women University, Multan, Pakistan.

Rehan Sadiq Shaikh (RS)

Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Multan, Pakistan.
Center for Applied Molecular Biology, University of the Punjab, Lahore, Pakistan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH